Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging Study of Olmesartan Medoxomil in Children and Adolescents With Hypertension
2015-003329-32Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2015-003329-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003329-32.